Can Macrobid (nitrofurantoin) treat a Group B Streptococcus (GBS) urinary tract infection (UTI) in a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Macrobid Treat Group B Strep UTI?

Nitrofurantoin (Macrobid) can effectively treat Group B Streptococcus urinary tract infections in pregnant women, with all GBS isolates showing susceptibility to this agent, but any pregnant woman with GBS bacteriuria at any concentration must also receive intrapartum IV antibiotic prophylaxis during labor regardless of prior treatment. 1

Treatment of the Acute UTI

  • Nitrofurantoin is an appropriate and effective choice for treating GBS UTI during pregnancy, as research demonstrates 100% susceptibility of GBS isolates to this antibiotic with only 2% showing intermediate sensitivity. 1

  • The acute UTI should be treated according to current standards of care for urinary tract infections during pregnancy using pregnancy-safe antibiotics. 2, 3

  • Alternative first-line options for treating the acute infection include amoxicillin 500 mg three times daily for 3 days or first-generation cephalosporins. 4, 5

  • Complete the full prescribed course to ensure eradication and prevent recurrence, though this will NOT eliminate GBS colonization from the genitourinary tract—recolonization after oral antibiotics is typical. 2

Critical Requirement: Intrapartum Prophylaxis

  • All pregnant women with GBS bacteriuria at any concentration during any trimester of the current pregnancy must receive intrapartum IV antibiotic prophylaxis during labor, regardless of whether the UTI was treated earlier in pregnancy. 6, 2, 3

  • GBS bacteriuria is a marker for heavy genital tract colonization and significantly increases the risk of early-onset neonatal GBS disease. 2, 3

  • These women do NOT need additional GBS screening at 35-37 weeks' gestation—the presence of GBS bacteriuria at any point automatically qualifies them for intrapartum prophylaxis. 3

Intrapartum Prophylaxis Regimens

For women without penicillin allergy:

  • Penicillin G 5 million units IV initially, then 2.5 million units IV every 4 hours until delivery (preferred agent due to narrow spectrum). 2
  • Ampicillin 2 g IV initially, then 1 g IV every 4 hours until delivery (acceptable alternative). 2

For penicillin-allergic patients not at high risk for anaphylaxis:

  • Cefazolin 2 g IV initially, then 1 g IV every 8 hours until delivery (preferred alternative). 2

For patients at high risk for anaphylaxis:

  • Clindamycin 900 mg IV every 8 hours if the isolate is confirmed susceptible. 2
  • Vancomycin 1 g IV every 12 hours if susceptibility testing unavailable or isolate resistant to clindamycin. 2

Why Both Treatments Are Necessary

  • Treating the UTI with oral antibiotics like nitrofurantoin addresses the acute infection but does NOT eliminate GBS colonization from the genitourinary tract—this is why intrapartum IV prophylaxis remains mandatory even after successful UTI treatment. 2

  • Intrapartum prophylaxis administered ≥4 hours before delivery is 78% effective in preventing early-onset neonatal GBS disease. 2

  • Attempting to eradicate GBS colonization before labor with repeated courses of antibiotics is ineffective and may cause adverse consequences including antibiotic resistance. 6, 3

Important Clinical Pitfalls to Avoid

  • Do not assume that treating the UTI eliminates the need for intrapartum prophylaxis—this is the most critical error, as GBS recolonization is typical after oral antibiotics. 2, 3

  • Do not withhold intrapartum prophylaxis even if subsequent cultures are negative—the history of GBS bacteriuria during the current pregnancy mandates prophylaxis. 3

  • Intrapartum prophylaxis is not needed only if cesarean delivery is performed before onset of labor on a woman with intact amniotic membranes. 6, 3

Context for Non-Pregnant Patients

  • In non-pregnant patients, GBS bacteriuria should only be treated if symptomatic or if underlying urinary tract abnormalities exist—asymptomatic bacteriuria should not be treated in this population. 7

  • The universal treatment mandate for any concentration of GBS in urine applies specifically to pregnant women to prevent neonatal disease and should not be applied to non-pregnant patients. 7

References

Research

Antibiotic resistance patterns of group B streptococcal clinical isolates.

Infectious diseases in obstetrics and gynecology, 2004

Guideline

Treatment of Group B Streptococcal UTI in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Group B Streptococcus UTI in First Trimester of Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Urinary tract infections in pregnancy.

Current opinion in urology, 2001

Research

Recommended treatment for urinary tract infection in pregnancy.

The Annals of pharmacotherapy, 1994

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Group B Streptococcus Urinary Tract Infection in Non-Pregnant Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.